Streptozotocin-Induced Diabetes Causes Metabolic Changes and Alterations in Neurotrophin Content and Retrograde Transport in the Cervical Vagus Nerve

This publication has 51 references indexed in Scilit:

• Transforming growth factor-β1 and glial growth factor 2 reduce neurotrophin-3 mRNA expression in cultured Schwann cells via a cAMP-dependent pathway
  Molecular Brain Research, 1999
• Elevated expression of neurotrophin-3 mRNA in sensory nerve of streptozotocin-diabetic rats
  Neuroscience Letters, 1999
• Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats
  Diabetologia, 1998
• Diabetes and axotomy-induced deficits in retrograde axonal transport of nerve growth factor correlate with decreased levels of p75LNTR protein in lumbar dorsal root ganglia
  Molecular Brain Research, 1997
• Altered Neurotrophin mRNA Levels in Peripheral Nerve and Skeletal Muscle of Experimentally Diabetic Rats
  Journal of Neurochemistry, 1995
• Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: Effects of insulin treatment
  Neuroscience, 1994
• The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort
  Neurology, 1993
• Macrophage dependence of peripheral sensory nerve regeneration: Possible involvement of nerve growth factor
  Neuron, 1991
• Vagus Nerve Morphology in Diabetic Gastropathy
  Diabetic Medicine, 1990
• Functional and histological studies of the vagus nerve and its branches to the heart, lungs and abdominal viscera in the cat
  The Journal of Physiology, 1957